Literature DB >> 22726396

Association of epicardial fat thickness with the severity of obstructive sleep apnea in obese patients.

Stefania Mariani1, Daniela Fiore, Giuseppe Barbaro, Sabrina Basciani, Maurizio Saponara, Enzo D'Arcangelo, Salvatore Ulisse, Costanzo Moretti, Andrea Fabbri, Lucio Gnessi.   

Abstract

BACKGROUND: The correlation between obesity and severity of obstructive sleep apnea (OSA) is controversial. Although fat excess is a predisposing factor for the development of OSA, it has not been determined whether fat distribution rather than obesity per se is associated with OSA severity. Epicardial fat thickness (EFT) is an independent index of visceral adiposity and cardiometabolic risk. We investigated the relation between fat distribution and cardiometabolic risk factors, including EFT and common carotid intima-media thickness (cIMT), with the severity of OSA in obese patients.
METHODS: One hundred and fifteen obese patients (56 males, 59 females) with polysomnographic evidence of OSA (≥ 5 apnea/hypopnea events per hour) of various degrees, without significant differences in grade of obesity as defined by body mass index (BMI), were evaluated. The following parameters were measured: BMI, body composition by dual energy X-ray absorptiometry, EFT, right ventricular end-diastolic diameter (RVEDD) and cIMT by ultrasound, and parameters of metabolic syndrome (waist circumference, arterial blood pressure, fasting glucose, HDL-cholesterol and triglycerides).
RESULTS: EFT, RVEDD, cIMT and trunk/leg fat mass ratio showed a positive correlation with OSA severity in univariate analysis (r=0.536, p<0.001; r=0.480, p<0.001; r=0.345, p<0.001; r=0.330, p<0.001, respectively). However, multiple linear regression analysis showed that EFT was the most significant independent correlate of the severity of OSA (R(2)=0.376, p=0.022).
CONCLUSIONS: The present study suggests that, in obese patients, EFT may be included among the clinical parameters associating with OSA severity. The association of EFT with OSA, both cardiovascular risk factors, is independent of obesity as defined by classical measures.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Body composition; Cardiovascular risk factor; Epicardial fat; Obesity; Obstructive sleep apnea

Mesh:

Year:  2012        PMID: 22726396     DOI: 10.1016/j.ijcard.2012.06.011

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  22 in total

1.  Sleep Apnea and Cancer: Analysis of a Nationwide Population Sample.

Authors:  David Gozal; Sandra A Ham; Babak Mokhlesi
Journal:  Sleep       Date:  2016-08-01       Impact factor: 5.849

2.  Epicardial fat accumulation is an independent marker of impaired heart rate recovery in obese patients with obstructive sleep apnea.

Authors:  Astrid Monfort; Jocelyn Inamo; Cedric Fagour; Rishika Banydeen; Lievyn Enette; Patrick Rene-Corail; Emmanuel Rivkine; Remi Neviere
Journal:  Clin Res Cardiol       Date:  2019-03-18       Impact factor: 5.460

3.  Androgen receptor gene and sex-specific Alzheimer's disease.

Authors:  Raffaele Ferrari; Saad Dawoodi; Merrill Raju; Avinash Thumma; Linda S Hynan; Shirin Hejazi Maasumi; Joan S Reisch; Sid O'Bryant; Marjorie Jenkins; Robert Barber; Parastoo Momeni
Journal:  Neurobiol Aging       Date:  2013-03-29       Impact factor: 4.673

4.  Epicardial fat thickness and cardiovascular involvements.

Authors:  Sevket Balta; Mustafa Demır; Ali Osman Yıldırım; Sait Demırkol; Cengiz Ozturk; Turgay Celık
Journal:  Afr Health Sci       Date:  2015-12       Impact factor: 0.927

5.  Epicardial fat thickness regression with continuous positive airway pressure therapy in patients with obstructive sleep apnea: assessment by two-dimensional echocardiography.

Authors:  Süha Çetin; Mustafa Gökhan Vural; Hüseyin Gündüz; Ramazan Akdemir; Hikmet Fırat
Journal:  Wien Klin Wochenschr       Date:  2016-03-10       Impact factor: 1.704

6.  Plasma levels of SIRT1 associate with non-alcoholic fatty liver disease in obese patients.

Authors:  Stefania Mariani; Daniela Fiore; Sabrina Basciani; Agnese Persichetti; Savina Contini; Carla Lubrano; Luisa Salvatori; Andrea Lenzi; Lucio Gnessi
Journal:  Endocrine       Date:  2014-10-31       Impact factor: 3.633

7.  Severe growth hormone deficiency and empty sella in obesity: a cross-sectional study.

Authors:  Carla Lubrano; Marta Tenuta; Daniela Costantini; Palma Specchia; Giuseppe Barbaro; Sabrina Basciani; Stefania Mariani; Alfredo Pontecorvi; Andrea Lenzi; Lucio Gnessi
Journal:  Endocrine       Date:  2015-01-23       Impact factor: 3.633

8.  CPAP therapy induces favorable short-term changes in epicardial fat thickness and vascular and metabolic markers in apparently healthy subjects with obstructive sleep apnea-hypopnea syndrome (OSAHS).

Authors:  Konstantinos Kostopoulos; Emmanouil Alhanatis; Konstantinos Pampoukas; Georgios Georgiopoulos; Andromahi Zourla; Athanasios Panoutsopoulos; Anastasios Kallianos; Lemonia Velentza; Paul Zarogoulidis; Georgia Trakada
Journal:  Sleep Breath       Date:  2015-07-30       Impact factor: 2.816

9.  Circulating SIRT1 Increases After Intragastric Balloon Fat Loss in Obese Patients.

Authors:  Stefania Mariani; Daniela Fiore; Agnese Persichetti; Sabrina Basciani; Carla Lubrano; Eleonora Poggiogalle; Alfredo Genco; Lorenzo Maria Donini; Lucio Gnessi
Journal:  Obes Surg       Date:  2016-06       Impact factor: 4.129

10.  Impact of lifestyle on metabolic syndrome in apparently healthy people.

Authors:  Silvio Buscemi; Delia Sprini; Giuseppe Grosso; Fabio Galvano; Antonio Nicolucci; Giuseppe Lucisano; Fatima M Massenti; Emanuele Amodio; Giovam B Rini
Journal:  Eat Weight Disord       Date:  2014-04-03       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.